ArticleThe Yale journal of biology and medicine2026
A Case of Early-Onset VCP-Related Frontotemporal Dementia: Insights from Neuroimaging and Genetic Analysis.
Article in The Yale journal of biology and medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Frontotemporal dementia (FTD) is a neurodegenerative disorder characterized by focal neuronal loss in the frontal and temporal cortices. Although microtubule-associated protein tau, granulin, and C9orf72 mutations are common in behavioral variant FTD (bvFTD), there are also less common variants. This case highlights a 48-year-old man with a diagnosis of bvFTD with valosin-containing protein (VCP) mutation based on comprehensive clinical, genetic, and neuroimaging findings. Methods: The patient underwent neurological, psychiatric, and neuropsychological assessments, along with magnetic resonance imaging (MRI) and positron emission tomography (PET) imaging using 18F-FDG. Whole genome sequencing was performed to identify potential pathogenic variants. Results: The patient exhibited severe neurobehavioral symptoms, including paranoia, emotional disconnection, and cognitive decline, ultimately leading to suicide. Although MRI findings were unremarkable, PET imaging revealed regional lower glucose metabolism (range from -1.7% to -16.5%). Whole genome sequencing identified a pathogenic VCP mutation (NM_001354927). Conclusions: This case highlights a well-documented case of VCP-related bvFTD and the utility of advanced and novel PET imaging in identifying functional deficits despite normal structural MRI. Integrating genetic testing and neuroimaging is crucial for accurate diagnosis and better understanding of genotype-phenotype correlations in rare FTD variants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.